Compare, Analyse Dr. Reddys with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs ACTAVIS (US) - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   ACTAVIS
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-19
ACTAVIS
Dec-18
DR. REDDYS LAB/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs2,87513,746-   
Low Rs1,8889,221-   
Sales per share (Unadj.) Rs930.23,371.9-  
Earnings per share (Unadj.) Rs117.4-1,086.1-  
Cash flow per share (Unadj.) Rs185.8355.3-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs844.413,907.7-  
Shares outstanding (eoy) m166.07332.60-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.63.4 75.2%   
Avg P/E ratio x20.3-10.6 -191.8%  
P/CF ratio (eoy) x12.832.3 39.7%  
Price / Book Value ratio x2.80.8 341.6%  
Dividend payout %17.00-   
Avg Mkt Cap Rs m395,4963,819,451 10.4%   
No. of employees `00022.016.9 130.0%   
Total wages/salary Rs m33,5620-   
Avg. sales/employee Rs Th7,032.866,361.4 10.6%   
Avg. wages/employee Rs Th1,527.90-   
Avg. net profit/employee Rs Th887.7-21,375.1 -4.2%   
INCOME DATA
Net Sales Rs m154,4821,121,508 13.8%  
Other income Rs m3,37521,447 15.7%   
Total revenues Rs m157,8571,142,955 13.8%   
Gross profit Rs m31,78229,389 108.1%  
Depreciation Rs m11,348479,421 2.4%   
Interest Rs m88964,717 1.4%   
Profit before tax Rs m22,920-493,302 -4.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m4380-   
Extraordinary Inc (Exp) Rs m0125,812 0.0%   
Tax Rs m3,858-6,252 -61.7%   
Profit after tax Rs m19,500-361,238 -5.4%  
Gross profit margin %20.62.6 785.1%  
Effective tax rate %16.81.3 1,328.2%   
Net profit margin %12.6-32.2 -39.2%  
BALANCE SHEET DATA
Current assets Rs m111,101459,984 24.2%   
Current liabilities Rs m58,973406,917 14.5%   
Net working cap to sales %33.74.7 713.1%  
Current ratio x1.91.1 166.7%  
Inventory Days Days7920 405.1%  
Debtors Days Days9466 142.1%  
Net fixed assets Rs m101,245126,948 79.8%   
Share capital Rs m8300-   
"Free" reserves Rs m139,4060-   
Net worth Rs m140,2364,625,699 3.0%   
Long term debt Rs m22,0001,628,876 1.4%   
Total assets Rs m224,6567,231,020 3.1%  
Interest coverage x26.8-6.6 -404.4%   
Debt to equity ratio x0.20.4 44.6%  
Sales to assets ratio x0.70.2 443.4%   
Return on assets %9.1-4.1 -221.3%  
Return on equity %13.9-7.8 -178.1%  
Return on capital %14.9-4.8 -308.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m69,5690-   
CASH FLOW
From Operations Rs m28,704400,673 7.2%  
From Investments Rs m-7,727220,117 -3.5%  
From Financial Activity Rs m-21,326-687,674 3.1%  
Net Cashflow Rs m-314-66,550 0.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.04 Rs / USD

Compare DR. REDDYS LAB With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare DR. REDDYS LAB With: FDC LTD.  BIOCON   WYETH LTD  DISHMAN PHARMA  J.B.CHEMICALS  



Today's Market

Sensex Opens Higher; Consumer Durables and Energy Stocks Lead(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 1.7% while the Hang Seng is down 0.1%.

Related Views On News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Oct 15, 2019 11:33 AM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS